Novel acridine-based compounds that exhibit an anti-pancreatic cancer activity are catalytic inhibitors of human topoisomerase II - Oppegard, L M; Ougolkov, A V; Luchini, D N; Schoon, R A; Goodell, J R; Kaur, H; Billadeau, D D; Ferguson, D M; Hiasa, H (Eur J Pharmacol, 2009)